Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Am J Prev Med. 2014 Apr;46(4):368–377. doi: 10.1016/j.amepre.2013.11.009

Table 2. Primary outcomes for e-Care participants who completed the follow-up visit, n=90.

Control Web-dietitian Adjusted
difference
between
groups
P-
valuee

Patients completing follow-up
visit
46 44
Systolic BP (mmHg)
  Unadjusted M (SD) 139.1 (14.1) 136.4 (13.9)
  Adjusteda M change (95%
  CI)
−11.4 (−15.4,
−7.3)
−13.9 (−18.1, −9.8) −2.6 (−8.6,
3.4)
0.40

Diastolic BP (mmHg)
  Unadjusted M (SD) 84.6 (9.5) 84.0 (10.2)
  Adjusteda M change (95%
  CI)
−6.6 (−9.2, −3.9) −8.5 (−11.3, −5.8) −2.0 (−6.0,
2.0)
0.32

Weight (kg)
  Unadjusted M (SD) 99.7 (17.4) 97.0 (17.6)
  Adjusteda M change (95%
  CI)
−0.5 (−1.6, 0.7) −3.7 (−4.9, −2.5) −3.2 (−5.0,
−1.5)
<0.01

CVD risk scoreb
  Unadjusted M (SD) 13.8 (4.8) 11.4 (4.4)
  Adjusteda M change (95%
  CI)
−2.8 (−3.9, −1.7) −4.1 (−5.2, −3.0) −1.3 (−2.9,
0.3)
0.10

BP control
  Number controlled (%) 18 (39.1) 24 (54.5)
  Adjustedc relative risk
  (95% CI)
1.00 (ref) 1.39 (0.88, 2.21) 0.16

Weight loss ≥4 kg
  Number lost ≥4 kg (%) 5 (10.9) 14 (31.8)
  Adjustedd relative risk
  (95% CI)
1.00 (ref) 2.96 (1.16, 7.53) 0.02
a

Adjusted for gender and the baseline measure of the outcome.

b

Missing values: CVD risk (4).

c

Adjusted for gender, baseline systolic BP, and BMI.

d

Adjusted for gender and baseline weight.

e

p-values from adjusted analyses.

BP, blood pressure; CVD, cardiovascular disease